Leucine bags $7 Mn to make pharma manufacturing safer with its AI tech stack
B2B software-as-a-service (SaaS) platform Leucine has raised $7 Mn as part of its Series A funding round led by Ecoloab. The round also saw participation from Pravega Ventures, Axilor Ventures, Techstars, and other angel investors. The startup plans to utilise the funds to scale up its tech stack and refine its AI capabilities. The fresh capital will also be deployed to expand its footprint and increase its reach to more customers.